viracta.com (VIRX): Expected earnings per share growth for next year

Public company logo of viracta.com (VIRX)

Compliance with FDA biomaterial disposal regulations defines the operational backdrop, which smooths the expected EPS growth for next year, where the current level is 0.00. Growth at Viracta Therapeutics (VIRX) is based on innovations in lymphoma therapy via the activation of dormant viruses. Personnel stability is ensured by RSU programs and the scientific significance of the tasks for oncology researchers.

VIRX: Viracta Consensus forecast of earnings per share growth for next year 07/04/2022 - 02/16/2025

Analytical breakdowns and data insights for company Viracta Therapeutics Inc. (VIRX)

- share price and consensus valuation forecast:
Comprehensive company analysis:Viracta Therapeutics
Finished products of Viracta Therapeutics, Inc.

The high scaling potential of Viracta Therapeutics (VIRX), driven by the patent protection of innovative oncology drugs, determines the future profitability of the business. By analyzing this chart of expected EPS growth over 12 months, an investor assesses the market consensus on net income dynamics, which allows for the rapid identification of the impact of rising costs on future earnings and the determination of the company's capitalization stability.

Direct competitors

ONC (BeiGene Ltd) - Earnings growth forecast for next year|Expected net earnings per share growth next year Halozyme Therapeutics HALO|Net earnings per share growth forecast for next year Revolution Medicines, Inc. (RVMD)|Earnings growth forecast for next year Ascentage Pharma Group International (AAPG)|Earnings growth forecast for next year CGON (CG Oncology Inc)|Expected earnings per share trend next year URGN|bicara.com - Earnings growth forecast for next year|Expected earnings per share trend next year PSNL (personalis.com)|Erasca Inc (ERAS) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year Delcath Systems|YMAB (YmAbs) - Earnings growth forecast for next year|AURA: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Candel Therapeutics, Inc. (CADL)|Earnings growth forecast for next year Accuray (ARAY)|Net earnings per share growth forecast for next year SELLAS Life Sciences Group Inc. SLS|Actuate Therapeutics, Inc (ACTU) - Expected net earnings per share growth next year|CTOR - Net earnings per share growth forecast for next year|HURA: Net earnings per share growth forecast for next year|TARA (Protara) - Expected earnings per share growth for next year|Fate Therapeutics, Inc. - Expected earnings per share trend next year|WHWK (aadibio.com) - Earnings growth forecast for next year|TCRX: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Champions Oncology (CSBR)|XBiotech - Projected earnings per share growth rate for next year|Net earnings per share growth forecast for next year CEL-SCI CVM|Consensus forecast of earnings per share growth for next year OS Therapies (OSTX)|Radiopharm Theranostics Limited - Earnings growth forecast for next year|Expected net earnings per share growth next year Artiva Biotherapeutics|ANL (adlainortye.com) - Expected earnings per share growth for next year|Expected earnings per share growth for next year Veru Pharma|TPST (Tempest Therapeutics Inc) - Earnings growth forecast for next year|Xilio Therapeutics, Inc. (XLO) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Enochian BioSciences (RENB)|MURA: Net earnings per share change forecast for next year|Earnings growth forecast for next year KAPA (kairospharma.com)|Consensus forecast of earnings per share growth for next year OnKure (OKUR)|CytoMed Therapeutics Ltd - Earnings growth forecast for next year|curis.com (CRIS) - Expected earnings per share growth for next year|Apollomics Corp (APLM) - Net earnings per share growth forecast for next year|Tharimmune - Expected earnings per share trend next year|ADVB (Advanced Biomed Corp) - Earnings growth forecast for next year|Expected earnings per share growth for next year Genprex, Inc (GNPX)|Earnings growth forecast for next year CLDI|SBFM: Net earnings per share change forecast for next year|Earnings growth forecast for next year XBIO (xeneticbio.com)|Earnings growth forecast for next year Salarius Pharmaceuticals Inc SLRX|purple-biotech.com - Earnings growth forecast for next year|Expected net earnings per share growth next year American Oncology Network, Inc.|BGNE: Earnings growth forecast for next year|Expected earnings per share growth for next year checkpointtx.com|Net earnings per share growth forecast for next year Elevation Oncology, Inc.|iCAD, Inc. (ICAD) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Ikena (IKNA)|NTBL - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year MorphoSys Inc MOR|Expected earnings per share trend next year NAYA|AAPGV: Expected earnings per share growth for next year